EVALUATION OF BOTULINUM NEUROTOXIN-A IN THE TREATMENT OF MASSETER MUSCLE HYPERTROPHY AMONG A SAMPLE OF IRAQI PATIENTS

Authors

  • Ghufran Majid Hayder Al-karkh General Hospital, Ministry of Health, Iraq
  • Mohammed Ahmed Rasheed M.B.Ch.B/ F.I.B.M.S (Rad)/ EdiR, Ministry of Health, Iraq
  • Mohammed Abbood Al-Maliky Department of Dentistry, Al-Hadi University College, Baghdad-10011, Iraq.

Keywords:

Botulinum neurotoxin, masseter muscle, hypertrophy

Abstract

Masseteric muscle hypertrophy is considered a benign disease that is characterized by the enlargement of the masseter muscles. Botulinum neurotoxin-A is considered one of the most poisonous biological materials known

References

Yamaguchi K, Tohara H, Hara K, Nakane A, Kajisa E, Yoshimi K, et al. Relationship of aging, skeletal muscle mass, and tooth loss with masseter muscle thickness. BMC Geriatrics. 2018;18(1):67.

Keser G, Bayrakdar IS, Pekiner FN, Çelik Ö, Orhan K. A deep learning approach for masseter muscle segmentation on ultrasonography. Journal of Ultrasonography. 2022;22(91):e204-e208.

Fromage G. The uses of botulinum toxin A in facial aesthetics. Journal of Aesthetic Nursing. 2020;9(10):414-419.

Mezey SE, Müller-Gerbl M, Toranelli M, Türp JC. The human masseter muscle revisited: First description of its coronoid part. Annals of Anatomy - Anatomischer Anzeiger. 2022;240:151879.

Kato K, Matsuda N, Takahata M, Sato T. Difference in measurement methods of masseter muscle function in healthy young adults; occlusal force meter and ultrasound imaging systems. Structure and Function. 2020;18(2):95-100.

Iwasaki M, Hirano H, Motokawa K, Shirobe M, Edahiro A, Ohara Y, et al. Interrelationships among whole-body skeletal muscle mass, masseter muscle mass, oral function, and dentition status in older Japanese adults. BMC Geriatrics. 2021;21(1):582.

Yeh YT, Peng JH, Peng HLP. Literature review of the adverse events associated with botulinum toxin injection for the masseter muscle hypertrophy. Journal of cosmetic dermatology. 2018;17(5):675-687.

Singh S, Shivamurthy DM, Agrawal G, Varghese D. Surgical management of masseteric hypertrophy and mandibular retrognathism. Natl J Maxillofac Surg. 2011;2(1):96-99.

Kundu N, Kothari R, Shah N, Sandhu S, Tripathy DM, Galadari H, et al. Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring. Journal of Cosmetic Dermatology. 2022;21(5):1849-1856.

Almukhtar RM, Fabi SG. The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review. Plastic and Reconstructive Surgery. 2019;143(1):39e-48e.

Shamshoddin DRBD. A Review on Botulinum Toxin Safety and Efficacy in Treatment of Blepharospasm and Hemifacial Spasm. IOSR Journal of Dental and Medical Sciences. 2021;20(2):28-37.

Spare NM, Mazuera-Mejia SM, Gehret JA. Trigeminal Neuralgias. In: Freedman MK, Gehret JA, Young GW, Kamen LB, editors. Challenging Neuropathic Pain Syndromes: Elsevier; 2018. p. 177-186.

Raman S, Yamamoto Y, Suzuki Y, Matsuka Y. Mechanism and clinical use of botulinum neurotoxin in head and facial region. Journal of Prosthodontic Research. 2023:JPR_D_22_00238.

Haroutounian S, Finnerup NB. Chapter 50 - Recommendations for Pharmacologic Therapy of Neuropathic Pain. In: Benzon HT, Raja SN, Liu SS, Fishman SM, Cohen SP, editors. Essentials of Pain Medicine (Fourth Edition): Elsevier; 2018. p. 445-456.e442.

Goetz LL, Klausner AP. Neurogenic Lower Urinary Tract Dysfunction. In: Cifu DX, editor. Braddom's Physical Medicine and Rehabilitation (Sixth Edition). Philadelphia: Elsevier; 2021. p. 389-406.e382.

Bianco E, Tagliabue R, Mirabelli L, Maddalone M. Assessment of Electromyographic Changes in a Patient with Masseter Hypertrophy and Muscle Pain after Botulinum Injections: A Case Report and 5 Months Follow-up. The Journal of Contemporary Dental Practice. 2022;23(2):226-231.

Diracoglu D, Sahbaz T, Alptekin K, Dogan N. Effects of ultrasound-assisted botulinum neurotoxin-A injection in patients with bruxism and masseter hypertrophy. Turk J Phys Med Rehabil. 2021;67(3):351-356.

Klein FHdMdS, Brenner FM, Sato MS, Robert FMBR, Helmer KA. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy. Anais brasileiros de dermatologia. 2014;89:878-884.

Kim N-H, Park R-H, Park J-B. Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle. Plastic and Reconstructive Surgery. 2010;125(6):1693-1705.

Bhattacharjee K, Singh M, Bhattacharjee H. Extended effect after a single dose of type A botulinum toxin for asymmetric masseter muscle hypertrophy. Indian Journal of Plastic Surgery. 2015;48(02):196-199.

Lee H-J, Kim S-J, Lee K-J, Yu H-S, Baik H-S. Repeated injections of botulinum toxin into the masseter muscle induce bony changes in human adults: A longitudinal study. The Korean Journal of Orthodontics. 2017;47(4):222-228.

Chen Y, Tsai C-H, Bae TH, Huang C-Y, Chen C, Kang Y-N, et al. Effectiveness of Botulinum Toxin Injection on Bruxism: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Aesthetic Plastic Surgery. 2023;47(2):775-790.

Downloads

Published

2023-06-30

How to Cite

Ghufran Majid Hayder, Mohammed Ahmed Rasheed, & Mohammed Abbood Al-Maliky. (2023). EVALUATION OF BOTULINUM NEUROTOXIN-A IN THE TREATMENT OF MASSETER MUSCLE HYPERTROPHY AMONG A SAMPLE OF IRAQI PATIENTS. World Bulletin of Public Health, 23, 209-215. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/2982

Issue

Section

Articles